Divi’s Labs This fall Outcomes: Revenue elevated by 23% in March quarter, will give the ultimate dividend of ₹ 30 to shareholders
Divi’s Labs March Quarter Outcomes: Prescription drugs firm Divi’s Laboratories’ January-March 2025 led to web consolidated earnings within the quarter by 23 p.c to Rs 662 crore on an annual foundation. It was Rs 538 crore a 12 months in the past. Consolidated income from the operations elevated by 12 p.c to Rs 2585 crore … Read more